TCL Archive Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays August 16, 1974
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983